Pharmaceutical Industry in
Petit-Lancy

Telix Pharmaceuticals (Switzerland) Sàrl

Since 1999 · 21–50 empl.

The core activity of Telix Pharmaceuticals is the development and manufacture of biopharmaceutical products, in particular targeted radiation products for the diagnosis and treatment of cancer and rare diseases.

Bionoltra SA

Since 2008 · 11–20 empl.

The core activity of BIONOLTRA SA is the development, manufacture and marketing of medical devices and products for orthopedics and urology, particularly for the treatment of osteoarthritis and other diseases affecting the musculoskeletal system and urology.

Pharmex SA

Since 2018 · 51–100 empl.

The company's core activity encompasses the development, manufacture, and marketing of products and services in the following areas: * Pharmaceuticals: development and manufacture of medicines and medical devices, including generics and OTC products * Cosmetics: development and manufacture of premium cosmetic products for the general consumer and pediatric care * Dietary supplements: development and manufacture of dietary supplements (Food Supplements) * Services: provision of Contract Manufacturing Organization (CMO) services for pharmaceuticals, cosmetics, and biocides, as well as research and development (R&D) services for these areas. Thus, the company offers a wide range of products and services focusing on the areas of health, beauty, and wellness.

BioSwiss Pharmaceutical SA

Since 2015 · 1–10 empl.

BioSwiss Pharmaceutical SA is a pharmaceutical company that manufactures and distributes prescription medicines and medical devices, with a focus on supplying markets that have limited access to treatments. The company commercializes products across multiple therapeutic areas (including anti-infectives, cardiology and oncology) and provides regulatory, supply-chain and licensing services in collaboration with compliant manufacturing partners.

Phidalsa SA

Since 1993 · 1–10 empl.

Neopharm SA

Since 2011 · 1–10 empl.

CAS Development SA

Since 2023 · 1–10 empl.